Differences in sexual behaviour and condom use among cocaine and opioid injectors in Santos, Toronto and London

International Journal of Drug Policy

Volumn 9, Issue 6, 1998, Pages 449-460

  Rhodes, Tim ^a   Millson, Margaret ^b   Bueno, Regina ^c   Myers, Ted ^b   Hunter, Gillian M ^a   Stimson, Gerry V ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c Inst Estud Pesq Em AIDS S   (Brazil)

Author keywords

Cocaine; Developing countries; HIV infection; HIV prevention; Injecting drug use; Opioids; Sexual behaviour

Indexed keywords

EID: 0348201735     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(98)00061-9     Document Type: Article

References (51)

1. Des Jarlais DC, Friedman SR, Choopanya K, Vanichensi S, Ward TP. (1992) International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992;6:1053-1068.
2. Rhodes T, Stimson GV, Quirk A. Sex, drugs, intervention and research: from the individual to the social. International Journal of Addiction 1996;31:375-407.
3. Friedman SR, Des Jarlais DC, Ward TP, Jose B, Neaigus A, Goldstein M. Drug injectors and heterosexual AIDS. In: Sherr L, editor. Heterosexual AIDS. Switzerland, Harwood, 1994.
4. Rhodes T, Myers T, Bueno R, Hunter GM, Millson P. Drug injecting and sexual safety: cross-national comparisons among cocaine and opioid injectors. In: Stimson GV, Des Jarlais DC, Ball A, editors. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London, Taylor and Francis, 1998.
5. Des Jarlais DC. Cross-national studies of AIDS among injecting drug users. Addiction 1994;89:383-92.
6. Stimson GV. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bulletin of Narcotics 1993;1:3-17.
7. Choopanya K, Vanichensi S, Plangsringarm K, et al. Risk factors and HIV seroposivity among injecting drug users in Bangkok. AIDS 1991;5:1509-13.
8. Lima ES, Bastos FI, Telles PR, Ward TP. Injecting drug users and the spread of HIV in Brazil. AIDS Public Policy 1992;7:170-4.
9. Stimson GV, Choopanya K. Global perspectives on drug injecting. In: Stimson GV, Des Jarlais DC, Ball A, editors. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London, Taylor and Francis, 1998.
10. Lima ES, Friedman SR, Bastos FI, Telles PR, Friedmann P, Ward TP, Des Jarlais DC. Risk factors for HIV-1 seroprevaluce among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction 1994;89:689-98.
11. Moss A. AIDS and intravenous drug use: the real heterosexual epidemic. British Medical Journal 1987;294:389-90.
12. Friedman SR, Jose B, Neaigus A, Goldstein M, Curtis R, Idefonso G, Mota P, Des Jarlais DC. Consistent condom use in relationships between seropositive drug users and sex partners who do not inject drugs. AIDS 1994;8:357-61.
13. Lewis DK, Watters JK. Sexual risk behaviour among heterosexual intravenous drug users: ethnic and gender variations. AIDS 1991;5:77-83.
14. WHO Collaborative Study Group. An international comparative study of HIV prevalence and risk behaviour among drug injectors in thirteen countries. In: UN Bulletin on Narcotics 1993;45:1946.
15. Stimson GV, Hunter GM, Donoghoe MC, Rhodes T, Parry J, Charmers CP. HIV prevalence in community-wide samples of injecting drug users in London (1993-1993). AIDS 1996;10:657-66.
16. Evans BG, Noone A, Mortimer J, et al. Heterosexually acquired HIV-1 infection: cases reported in England, Wales and Northern Ireland, 1985-1991. PHLS Communicable Disease Reports, 2 (April) 1992.
17. Battjes RJ, Pickens RW, Amsel Z, Brown LS. Heterosexual transmission of human immunodeficiency virus among intravenous drug users. Journal of Infectious Disease 1990;162:1007-11.
18. Soloman L, Astemborski J, Wamen D, Munoz A, Cohn S. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. American Journal of Epidemiology 1993;137:892-8.
19. Moss A, Vranizan K, Bacchetti P, Gorter R, Osmond D, Broadies B. Seroconversion for HIV in intravenous drug users in treatment, San Francisco 1985-1990. In: Sixth International Conference on AIDS, San Francisco, 1990.
20. Battjes RJ, Pickens RW, Haverkos HW, Sloboda Z. HIV risk factors among injecting drug users in five US cities. AIDS 1994;8:681-7.
21. Myers T, Cockerill R, Millson P, Rankin J, Worthington C. Canadian Communify Pharmacies HIV/AIDS Prevention and Health Promotion: Results of a National Survey. Toronto, University of Toronto, 1995.
22. Van Den Hoek JAR, Can Haastrecht HJA, Coutinho RA. Little change in sexual behaviour in injecting drug users in Amsterdam. Journal of Acquired Immune Deficiency Syndrome 1992;5:518-22.
23. Myers T, Millson P, Rigby J, Ennis M, Rankin J, Mindell W, Strathdee S. A comparison of the determinants of safe injecting and condom use among injecting drug users. Addiction 1995;90:217-26.
24. Abdul-Quader AS, Tross S, Friedman SR, Kouzi AC, Des Jarlais DC. Stree-recruited drug users and sexual risk reduction in New York City. AIDS 1990;4:1075-9.
25. Van Ameliden EJ, Van Den Hoek AAR, Van Haastrecht HJ, Coutinho RA. Trends in sexual behaviour and the incidence of sexually transmitted diseases and HIV among drug-using prostitutes, Amsterdam 1986-1992. AIDS 1994;8:213-221.
26. Watkins KE, Metzger D, Woody G, McLellan AT. Determinants of condom use among intravenous drug users. AIDS 1993;7:719-23.
27. Rhodes T. Risk theory in epidemic times: sex, drugs and the social organisation of risk behaviour. Sociology of Health and Illness 1997;19:208-28.
28. Sidthorpe B. The social construction of relationships as a determinant of HIV risk perception and condom use among injection drug users. Medical Anthropological Quarterly. 1992;6:255-70.
29. Rhodes, T, Quirk A. Heroin, risk and sexual safety: some problems for interventions encouraging community change. In: Rhodes T, Hartnoll R, editors. AIDS, Drugs and Prevention: Perspectives on Individual and Community Action. London: Routledge, 1996.
30. Rhodes T, Quirk A. Where is the sex in harm reduction? International Journal of Drug Policy 1995;6:76-82.
31. Chaisson MA, Stoneburner RL, Hilderbrandt WE, et al. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991;5:1121-6.
32. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Soloman L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. American Journal of Epidemiology 1991;134:1175-89.
33. Chirwin K, Dehovitz JA, Dillon A, McCormack WM. HIV infection, genital ulcer disease and crack cocaine use among patients attending a clinic for sexually transmitted diseases. American Journal of Public Health 1991;81:1576-9.
34. Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health 1993;83:1144-8.
35. Ratner M, Inciardi J, Bourgois P, et al. Crack Pipe as Pimp: An Eight-City Ethnographic Study of the Sex-For-Crack Phenomenon. Rockville: National Institute on Drug Abuse, 1992.
36. Rhodes T. Culture, drugs and unsafe sex: confusion about causation. Addiction 1996;6:753-8.
37. Rhodes T, Stimson GV. What is the relationship between drug taking and sexual risk? Sociology of Health and Illness 1994;16:209-29.
38. Myers T, Millson P, Rigby J, Rankin J, Midell W. Biographical characteristics of injection drug users and behavioural predispositions related to HIV prevention and drug use. Canadian Journal of Public Health 1994;86:176-80.
39. World Health Organization. Multi-City Study on Drug Injecting and Risk of HIV Infection, Programme on Substance Abuse. Geneva: WHO/PSA, 1994.
40. Connell JA, Parry JV, Mortimer PP, Duncan J. Novel assay for the detection of immunoglobin G antihuman immunodeficiency virus in untreated saliva and urine. Journal of Medical Virology 1993;41:159-64.
41. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet ii 1987:72-75.
42. Rhodes T, Donoghoe MC, Hunter GM, Soteri A, Stimson GV. Sexual behaviour of drug injectors in London: implications for HIV transmission and HIV prevention. Addiction 1994;89:1085-96.
43. Rhodes T, Bloor MJ, Donoghoe MC, et al. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. AIDS Care 1993;5:413-25.
44. Carael M, Cleland J, Deheneffe JC, Ferry B, Ingham R. Sexual behaviour in developing countries: implications for HIV control. AIDS 1995;9:1171-5.
45. Wadsworth J, Hickman M, Johnson AM, Wellings K, Field J. Geographical variation in sexual behaviour in Britian. AIDS 1996;10:193-9.
46. Tawil O, Verster A, O'Reilly KR. Enabling approaches for HIV/AIDS prevention: can we modify the environment and minimize the risk? AIDS 1995;9:1299-306.
47. Lurie P, Fernandes MEL, Highes V, Arevalo EI, Hudes ES, Reingold A, et al. Socioeconomic status and risk of HIV-1, syphilis and hepatitis B infection among sex workers in Sao Paulo State, Brazil. AIDS 1995;9(S1):S31-S37.
48. Bueno RC, Paes GL, Mesquita FC, et al. A comparison of IVDU and heterosexual transmission in sex workers of low social-economic situation in Santos. In: Eighth International Conference on AIDS. Amsterdam, PoC 4187, 1992.
49. Cortes E, Detels R, Slamon D, et al. Study of HIV-1, HIV-2 and HTLV-1 in female prostitutes in Brazil In: Fifth International Conference on AIDS. Montreal, M GP 13, 1989.
50. Rhodes T, Hartnoll R, editors. AIDS, Drugs and Prevention: Perspectives on Individual and Community Action. London: Routledge, 1996d.
51. Fisher DG, Needle R. AIDS and Community-Based Drug Intervention Programs. New York: Harrington Press, 1993.